Biocept Inc. (BIOCQ) — Financial Flexibility Index

Latest as of June 2023: -0.14x

Biocept Inc. (BIOCQ) has a Financial Flexibility Index of -0.14x as of June 2023. Free cash flow of $-2.99 Million (operating CF $-3.09 Million minus capex $97.00K) represents 0% of total liabilities ($21.81 Million). Also explore net asset momentum of Biocept Inc. to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.14x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-2.99 Million
Operating CF − Capex

Total Liabilities

$21.81 Million
USD

Capital Expenditures

$97.00K
USD

Biocept Inc. Financial Flexibility Index (2019–2022)

Historical Financial Flexibility Index trend for Biocept Inc. across 4 annual periods. See Biocept Inc. balance sheet independence to measure how much of total assets are equity-financed.

Annual Financial Flexibility Index for Biocept Inc. (2019–2022)

Year-by-year free cash flow to debt coverage for Biocept Inc.. For the full company profile including market capitalisation, see Biocept Inc. market cap and net worth.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2022 -0.57x $-12.48 Million $-13.29 Million $22.01 Million ▼ -347.2%
2021 0.23x $5.26 Million $3.69 Million $22.94 Million ▲ +128.8%
2020 -0.80x $-18.92 Million $-19.79 Million $23.76 Million ▲ +76.7%
2019 -3.42x $-22.31 Million $-23.05 Million $6.53 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities